InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Alter Jeffrey D., 董事. Insider active across 3 companies, notably PROGENITY, INC.. Cumulatively, 6 filings have been recorded. History available since 14 June 2021. The latest transaction was filed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Alter Jeffrey D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
12,500 股0Common StockSEC:0000950170-24-069926:0
12,500 股0Common StockSEC:0000950170-23-028595:0
65 股Series X Preferred StockSEC:0000899243-23-000961:0
96,154 股0Common StockSEC:0000899243-22-023091:0
311 股@ US$375.93100.0% 占其流量Common StockSEC:0001156039-21-000086:0
29,183 股0Common StockSEC:0000899243-21-024202:0
6 条申报中的 6 条
About Alter Jeffrey D.
Jeffrey D. Alter is a Board Member and EVP, IngenioRx & Anthem Health, involved with several companies including PROGENITY, INC., Anthem, Inc., and BIORA THERAPEUTICS, INC. He plays a key role in strategic direction and operational oversight, bringing his expertise in the healthcare sector.
